The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications.
Continue ReadingThe Celiac Disease Foundation and Celiac Cruise are pleased to announce an innovative partnership to offer safe and delicious gluten-free travel experiences, provide educational opportunities, and foster philanthropy within the celiac disease community.
Continue ReadingIn partnership with Celiac Cruise, the Celiac Disease Foundation was proud to embark on the inaugural sailing aboard Royal Caribbean’s Mariner of the Seas, January 17-20, 2020, and strengthen community relationships in gluten-free paradise.
Continue ReadingThe Celiac Disease Foundation is proud to attend the inaugural Celiac Cruise aboard Royal Caribbean’s Mariner of the Seas. Please visit their website to sign up for future cruise dates in October 2020 and March 2021.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...